Department of Psychiatry, Yale University School of Medicine, New Haven, CT, 06510, USA.
Child Study Center, Yale University School of Medicine, New Haven, CT, 06510, USA.
J Autism Dev Disord. 2019 Jul;49(7):2935-2945. doi: 10.1007/s10803-019-04020-1.
Individuals with autism spectrum disorder (ASD) often have co-morbid anxiety and depression. Alexithymia and emotion regulation difficulties are commonly seen in individuals with ASD and in mood disorders. We hypothesized that alexithymia and emotional regulation would mediate the relationship between autistic features and anxiety/depression symptom severity. We collected data about emotional regulation, alexithymia, autistic symptoms and depression/anxiety in a sample of 64 young adults with ASD. We constructed two serial multiple mediator models, using autistic features as the independent variable and anxiety/depression symptoms as outcome variables. The serial relationship between alexithymia and emotional regulation mediated associations between autistic features and depression and anxiety, separately. The findings suggest that targeting alexithymia may benefit therapies designed to alleviate mood disorders in ASD.
自闭症谱系障碍(ASD)患者常伴有共病性焦虑和抑郁。述情障碍和情绪调节困难在 ASD 患者和情绪障碍患者中很常见。我们假设述情障碍和情绪调节会在自闭症特征与焦虑/抑郁严重程度之间起中介作用。我们在 64 名 ASD 年轻成人样本中收集了有关情绪调节、述情障碍、自闭症症状和抑郁/焦虑的数据。我们构建了两个串联多重中介模型,使用自闭症特征作为自变量,焦虑/抑郁症状作为因变量。述情障碍和情绪调节之间的串联关系分别介导了自闭症特征与抑郁和焦虑之间的关联。研究结果表明,针对述情障碍可能有益于设计用于缓解 ASD 中情绪障碍的治疗方法。